Paulson, Loeb, Viking Suffer As Allergan-Pfizer Merger Falls Through

HFA Padded
HFA Staff
Published on
Updated on

Allergan’s stock nosedived on Monday, falling more than 20% as soon as the U.S Treasury announced its decision to pursue stricter rules to curb tax inversion mergers and buyouts. The Dublin-based pharmaceutical company was set to merge with U.S.-based Pfizer Inc. The Treasury’s announcement on Monday broke down the $160 billion AGN-PFE merger which was set to make the world’s largest pharmaceutical company, had it happened. Allergan-Pfizer breakup brings millions in losses Just as Allergan was getting burnt on Monday, a number of major hedge funds were feeling the losses. The largest shareholder among hedge funds, John Paulson, held over 5.5 million…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

The post above is drafted by the collaboration of the Hedge Fund Alpha Team.